Related Experiment Video
Updated: Jun 6, 2026
06:28
Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue
Published on: October 7, 2014
On the potential for molecular imaging with Cerenkov luminescence
Matthew A Lewis1, Vikram D Kodibagkar, Orhan K Öz
1Advanced Radiological Sciences, Department of Radiology, UT Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9058, USA. Matthew.Lewis@UTSouthwestern.edu
Optics Letters
|December 3, 2010
Summary
New preclinical optical imaging methods utilize beta decay luminescence. Fluorescence reporters convert Cerenkov luminescence for enhanced tissue penetration and molecular imaging strategies.
Area of Science:
- Biomedical optics
- Molecular imaging
- Radiochemistry
Background:
- Optical luminescence from beta decay offers novel preclinical imaging potential.
- Cerenkov radiation, a byproduct of beta decay, generates detectable photons.
- Current bioluminescence imaging instrumentation can detect Cerenkov photons.
Purpose of the Study:
- To explore the use of fluorescence reporters to enhance Cerenkov luminescence imaging.
- To enable longer wavelength emission for improved tissue penetration.
- To modulate luminescence spectra for advanced molecular imaging applications.
Main Methods:
- Simultaneous utilization of radiotracers emitting beta particles.
- Employing fluorescence reporters to down-convert Cerenkov luminescence.
- Characterizing spectral properties and tissue penetration of modified luminescence.
Main Results:
- Demonstrated conversion of Cerenkov luminescence to longer wavelengths.
- Achieved enhanced signal detection through spectral modulation.
- Showcased potential for improved depth imaging in preclinical models.
Conclusions:
- Fluorescence reporters can effectively modify Cerenkov luminescence characteristics.
- This approach advances preclinical optical imaging by improving tissue penetration and spectral control.
- Offers a promising strategy for future molecular imaging development.
